文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

自适应放疗方案对淋巴结阳性宫颈癌肠道保护的影响

Impact of Adapted Radiotherapy Schedules on Bowel Sparing in Node-Positive Cervical Cancer.
PubMed 文献 · Pract Radiat Oncol · 2022-12-17

本研究对5例淋巴结阳性宫颈癌患者的130次扫描进行计算机模拟,比较每日、每周、两次及无自适应四种放疗方案对小肠剂量的影响。结果显示自适应放疗频率越高,肠道保护越好,每日重新计划较非自适应方案使D2cc和D15cc平均降低2.7 Gy。

要点

  • 自适应放疗所有方案均较非自适应技术显著降低肠道剂量。
  • 每日重新计划较非自适应方案使D2cc和D15cc平均降低2.7 Gy。
  • 仅2次重新计划的最小自适应策略也较非自适应方案有显著剂量学获益。

核心结论

  • 所有评估的自适应放疗方案在肠道保护方面均较传统非自适应技术具有显著剂量学优势,且重新计划越频繁保护越好。

研究设计与样本

  • 对5例接受根治性外照射放疗的淋巴结阳性宫颈癌患者,获取130次可评估扫描(每例患者包括1次CT模拟定位和25次锥形束CT),在5周内每日进行。
  • 使用单一通用容积旋转调强放疗计划及预设优化优先级,创建每日、每周、两次和无自适应四种方案的自适应放疗计划。
  • 计算机模拟患者原发宫颈疾病接受45 Gy,受累淋巴结同时整合推量至55 Gy。

主要发现

  • 肠道剂量降低量与所选计划方案在所有评估指标中显著相关,且与自适应放疗频率成比例,具有显著的中至强单调性。
  • 每日重新计划较非自适应方法使D2cc和D15cc平均降低2.7 Gy。
  • 仅2次重新计划的最小自适应策略也较非自适应方法具有显著剂量学获益。
  • D2cc和V45肠道剂量在治疗过程中的标准差降低与计划方案选择显著相关,具有强单调性。

关键数值与推荐

  • 评估的剂量指标包括D2cc、D15cc和V45。
  • 原发宫颈放疗剂量为45 Gy,受累淋巴结同时整合推量至55 Gy。
  • 统计检验包括Student t检验、方差分析和Spearman秩相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出这些发现值得未来开展盆腔恶性肿瘤自适应放疗的临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Definitive radiation therapy (RT) for locally advanced node-positive cervical cancer confers significant toxicity to pelvic organs including the small bowel. Gross nodal disease exhibits significant shrinkage during RT, and yet conventional RT does not account for this change. We evaluated the reduction in absorbed bowel dose using various adaptive RT schedules. METHODS AND MATERIALS: We obtained 130 evaluable scans (computed tomography simulation and 25 cone beam computed tomography scans per patient) of 5 patients who had received definitive external beam RT for lymph node positive cervical cancer daily over 5 weeks. Using a single universal volumetric modulated arc therapy plan with predefined optimization priorities, we created adapted RT plans in 4 schedules: Daily, Weekly, Twice, and NoAdapt (mimicking conventional nonadapted RT). The in silico (computer modeled) patients were treated to 45 Gy to primary cervical disease with a simultaneous integrated boost to 55 Gy to involved lymph nodes. We evaluated dose metrics including D2cc, D15cc, and V45 to determine the impact of adapted RT schedules on bowel sparing. Statistical tests included the Student t test, analysis of variance, and the Spearman rank correlation. RESULTS: The quantity of reduced bowel dose was significantly associated with the chosen planning schedule in all evaluated metrics and was proportional to the frequency of adaptive RT with significant moderate-to-strong monotonicity. Both D2cc and D15cc were reduced an average of 2.7 Gy using daily replanning compared with a nonadapted approach. A minimally adapted strategy of only 2 replans also confers a significant dosimetric benefit over a nonadapted approach. Reduced standard deviations of D2cc and V45 bowel doses over the treatment courses were significantly associated with the choice of planning schedule with strong monotonicity. CONCLUSIONS: All adaptive RT schedules evaluated confer significant dosimetric advantages in bowel sparing over a conventional nonadapted technique, with greater sparing seen with more frequent replanning schedules. These findings warrant future trials of adaptive RT for pelvic malignancies.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Garrett MD, Li F, Lemus OD, et al. Impact of Adapted Radiotherapy Schedules on Bowel Sparing in Node-Positive Cervical Cancer. Pract Radiat Oncol. 2022. PMID: 36539155. doi:10.1016/j.prro.2022.11.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。